[1]
Ibrahim S, Dakik H, Vandier C, et al. Expression profiling of calcium channels and calcium-activated potassium channels in colorectal cancer. Cancers (Basel) 2019; 11(4): 561.
[http://dx.doi.org/10.3390/cancers11040561] [PMID: 31010205]
[http://dx.doi.org/10.3390/cancers11040561] [PMID: 31010205]
[2]
Ma G, Liu H, Hua Q, et al. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Mol Cancer 2017; 16(1): 46.
[http://dx.doi.org/10.1186/s12943-017-0613-z] [PMID: 28231797]
[http://dx.doi.org/10.1186/s12943-017-0613-z] [PMID: 28231797]
[3]
Hou JY, Wang YG, Ma SJ, Yang BY, Li QP. Identification of a prognostic 5-Gene expression signa-ture for gastric cancer. J Cancer Res Clin Oncol 2017; 143(4): 619-29.
[http://dx.doi.org/10.1007/s00432-016-2324-z] [PMID: 28035468]
[http://dx.doi.org/10.1007/s00432-016-2324-z] [PMID: 28035468]
[4]
Qin G, Yang L, Ma Y, Liu J, Huo Q. The exploration of disease-specific gene regulatory networks in esophageal carcinoma and stomach adenocarcinoma. BMC Bioinformatics 2019; 20(Suppl. 22): 717.
[http://dx.doi.org/10.1186/s12859-019-3230-6] [PMID: 31888440]
[http://dx.doi.org/10.1186/s12859-019-3230-6] [PMID: 31888440]
[5]
Hayashi M, Novak I. Molecular basis of potassium channels in pancreatic duct epithelial cells. Channels (Austin) 2013; 7(6): 432-41.
[http://dx.doi.org/10.4161/chan.26100] [PMID: 23962792]
[http://dx.doi.org/10.4161/chan.26100] [PMID: 23962792]
[6]
Khaitan D, Sankpal UT, Weksler B, et al. Role of KCNMA1 gene in breast cancer invasion and me-tastasis to brain. BMC Cancer 2009; 9: 258.
[http://dx.doi.org/10.1186/1471-2407-9-258] [PMID: 19640305]
[http://dx.doi.org/10.1186/1471-2407-9-258] [PMID: 19640305]
[7]
Du C, Zheng Z, Li D, et al. BKCa promotes growth and metastasis of prostate cancer through facili-tating the coupling between αvβ3 integrin and FAK. Oncotarget 2016; 7(26): 40174-88.
[http://dx.doi.org/10.18632/oncotarget.9559] [PMID: 27233075]
[http://dx.doi.org/10.18632/oncotarget.9559] [PMID: 27233075]
[8]
Ge L, Hoa NT, Wilson Z, et al. Big potassium (BK) ion channels in biology, disease and possible tar-gets for cancer immunotherapy. Int Immunopharmacol 2014; 22(2): 427-43.
[http://dx.doi.org/10.1016/j.intimp.2014.06.040] [PMID: 25027630]
[http://dx.doi.org/10.1016/j.intimp.2014.06.040] [PMID: 25027630]
[9]
Basile MS, Fagone P, Mangano K, et al. KCNMA1 expression is downregulated in colorectal cancer via epigenetic mechanisms. Cancers (Basel) 2019; 11(2): 245.
[http://dx.doi.org/10.3390/cancers11020245] [PMID: 30791468]
[http://dx.doi.org/10.3390/cancers11020245] [PMID: 30791468]
Related Books
Frontiers in Clinical Drug Research - Anti-Cancer Agents
NEOPLASIA and FERTILITY
Breast Cancer: Current Trends in Molecular Research
The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Topics in Anti-Cancer Research
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Modern Cancer Therapies and Traditional Medicine: An Integrative Approach to Combat Cancers
Herbal Medicine: Back to the Future
Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis
Article Metrics
22
1